Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Clinical trial NCT00725114 · COMPLETED
Trial details
- NCT number
- NCT00725114
- Sponsor
- Wex Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2012-11-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.